Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $24.1900 (-0.33%) ($24.1000 - $24.5700) on Mon. Jun. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.19% (three month average) | RSI | 45 | Latest Price | $24.1900(-0.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO declines -0.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(50%) IWM(46%) IWC(44%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -2.095% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.095% (StdDev 4.19%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
5 Day Moving Average | $24.04(0.62%) | 10 Day Moving Average | $24.08(0.46%) | 20 Day Moving Average | $24(0.79%) | To recent high | -2.5% | To recent low | 74% | Market Cap | $3.306b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |